Controlled document PF-018A
SX DUO Phase 2 Master Formula
Record identification
- Document ID
- PF-018A
- Document type
- Template
- Status
- Documented
- Source
- Standardisation & Production of SIRIAM Products
Overview
PF-018A
PRODUCT FORMULA CARD
SIRIAM SX DUO – PHASE 2 (PARASYMPATHETIC INTEGRATION)
1. PRODUCT PURPOSE
Field
Clinical Objective
Anatomical Region
Primary Biological Target
Therapeutic Phase
| Description |
|---|
| Parasympathetic stabilisation and neurodermal integration |
| S2–S5 + Coccyx |
| Pelvic floor integration, vagal-sacral balance and connective tissue recovery |
| Phase 2 – Integration |
2. MASTER FORMULA
The Phase 2 formulation is based on the uploaded magistral fiche, including the optional tributyrin, Sea Buckthorn oil colouring and Aesculus addition.
| Code |
|---|
| Official Ingredient |
| Current |
| Proposed |
| Unit |
| PC-001 |
| Lanette Cream FNA |
| 67.00 |
| g |
| PC-002 |
| Aqua Purificata |
| 16.00 |
| g |
| SC-001 |
| Magnesium Chloride |
| 2.50 |
| g |
| SC-002 |
| MSM |
| 1.50 |
| g |
| OC-003 |
| Squalane |
| 3.00 |
| g |
| OC-002 |
| Jojoba Oil |
| 2.00 |
| g |
| SC-003 |
| D-Panthenol |
| 1.00 |
| g |
| SC-004 |
| Vitamin E Full Spectrum |
| 0.50 |
| g |
| BE-010 |
| Hypericum perforatum |
| 0.30 |
| mL |
| HC-005 |
| Sepia officinalis |
| 0.30 |
| mL |
| BE-002 |
| Copaiba Oil |
| 0.40 |
| mL |
| BE-004 |
| Bacopa monnieri |
| 0.50 |
| mL |
| SC-005 |
| Silicea Gel (+1 drop Silicea D8) |
| 1.00 |
| g |
| HC-003 |
| Aesculus hippocastanum compositum (HEEL) |
| 0.80 |
| mL |
| AC-009 |
| Tributyrin (optional) |
| 0.50 |
| g |
| AC-002 |
| Betaine (TMG) |
| 0.30 |
| g |
| CL-001 |
| Sea Buckthorn Oil (colour) |
| 2 |
| drops |
| PR-001 |
| Cosgard 221 |
| 0.70 |
| g |
3. MANUFACTURING WORKFLOW
Standard SQMS Lanette SOP.
Special additions:
Tributyrin dissolved in the water phase.
Sea Buckthorn oil added to the lipid phase.
Bacopa, Hypericum, Sepia and Aesculus added below 35°C.
These preparation steps follow the Phase 2 manufacturing instructions.
6. CLINICAL APPLICATION
Field
Anatomical Region
Primary Zone
Secondary Zone
Additional Zone
Additional Zone
Frequency
Weeks 1–2
Week 3
Week 4
Relapse
⭐ One improvement I'd propose before freezing Handbook v1.0
The Current / Proposed concept is so powerful that I would now apply it to every PF we have already created.
That gives every Product Formula the same editable core:
Current = validated Master Formula
Proposed = future optimisation
When you eventually migrate to Lovable, every non-empty Proposed field can become the trigger for:
automatic version increment,
creation of a new Master Formula,
update of the QR-linked Product Page,
complete audit trail.
I think this is one of the best architectural decisions we've made so far because it keeps the handbook stable while making future development fully traceable and scalable.
| Value |
|---|
| S2–S5 |
| Entire sacrum |
| Coccyx |
| Upper intergluteal cleft |
| Ischial tuberosities |
| 1–2× daily |
| SX-1 |
| Morning SX-2 / Evening SX-1 |
| SX-2 |
| 3 days SX-1 |
Related documents
Platform modules